25 LLC’s National Healthcare NHC Stock Holding History

25 LLC’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9	Closed	-$516	–	369
2023 Q2	$516	Hold	9	–	–	﹤0.01%	508
2023 Q1	$512	Buy	+9	New	+$517	﹤0.01%	364

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

25 LLC's NHC Position: Q3 2023 in Review

25 LLC sold out of National Healthcare (NHC) in Q3 2023, closing a stake of 9 shares — an estimated $516 sold.

25 LLC first reported a position in NHC in Q1 2023 and held it in 2 quarters. The position peaked at $516 in Q2 2023. 131 funds tracked by Wall St. Rank hold NHC as of Q3 2023.

25 LLC reported no remaining National Healthcare position as of Q3 2023 after selling out during the quarter.
25 LLC sold 9 National Healthcare shares in Q3 2023, an estimated $516.
25 LLC first reported a position in National Healthcare in Q1 2023 and held it in 2 quarters.
25 LLC's National Healthcare position peaked at $516 in Q2 2023.
131 funds tracked by Wall St. Rank held National Healthcare as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.